Favezelimab
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Favezelimab, covering 2025-09-17 to 2026-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010) [Phase 2]